ARFORMOTEROL+GLYCOPYRRONIUM belongs to the group of medicines called bronchodilators indicated for long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining).
ARFORMOTEROL+GLYCOPYRRONIUM is a combination of two medicines, namely: Arformoterol (long-acting beta2-adrenergic agonist) and Glycopyrronium (anti-cholinergic). Arformoterol prevents tightening of the muscles in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium decreases the secretions in the airways. Together, ARFORMOTEROL+GLYCOPYRRONIUM provides relief from COPD.
You are advised to use ARFORMOTEROL+GLYCOPYRRONIUM for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, nausea, dry mouth, chest pain, muscle cramps, and dizziness. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Do not stop using ARFORMOTEROL+GLYCOPYRRONIUM on your own as it might cause worsening of symptoms. Consult your doctor before using ARFORMOTEROL+GLYCOPYRRONIUM if you are pregnant or breastfeeding. ARFORMOTEROL+GLYCOPYRRONIUM may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. ARFORMOTEROL+GLYCOPYRRONIUM is not recommended for children below 18years as the safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid unpleasant side effects.
Chronic Obstructive Pulmonary Disease (COPD).
ARFORMOTEROL+GLYCOPYRRONIUM is a combination of two medicines, namely: Arformoterol and Glycopyrronium. ARFORMOTEROL+GLYCOPYRRONIUM belongs to the group of medicines called bronchodilators used to treat Chronic Obstructive Pulmonary Disease (COPD). Arformoterol is a long-acting beta-agonist that prevents tightening of the muscles in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium is an anti-cholinergic that decreases the secretions in the airways. Together, ARFORMOTEROL+GLYCOPYRRONIUM provides relief from COPD.
Do not use ARFORMOTEROL+GLYCOPYRRONIUM if you are allergic to any of its contents. Inform your doctor if you have asthma, heart problems, seizures/epilepsy, thyroid gland problems, diabetes, narrow-angle glaucoma, kidney problems, severe liver problems, if you have any difficulty in passing urine or if you are taking any medicines for lung diseases. Consult your doctor before using ARFORMOTEROL+GLYCOPYRRONIUM if you are pregnant or breastfeeding. ARFORMOTEROL+GLYCOPYRRONIUM may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. ARFORMOTEROL+GLYCOPYRRONIUM is not recommended for children below 18years as the safety and effectiveness have not been established.
Drug-Drug Interaction: ARFORMOTEROL+GLYCOPYRRONIUM may have interaction with other bronchodilators (salmeterol, salbutamol/albuterol, ipratropium, formoterol), corticosteroids (fluticasone, budesonide), urinary medicines (darifenacin, oxybutynin), and medicines that are used to treat excess stomach acid.
Drug-Food Interaction: No interactions found/established.
Drug-Disease Interaction: Use ARFORMOTEROL+GLYCOPYRRONIUM cautiously with doctor's advice if you have narrow-angle glaucoma, difficulty in urination, heart problems, seizures, gastrointestinal obstruction, arrhythmia, hypertension, myasthenia gravis, and infectious diarrhoea.
You are advised not to consume alcohol while using ARFORMOTEROL+GLYCOPYRRONIUM as it might cause increased dizziness.
Please consult your doctor if you have any concerns regarding this; your doctor will prescribe only if the benefits outweigh the risks.
Consult your doctor before using ARFORMOTEROL+GLYCOPYRRONIUM; your doctor will decide whether ARFORMOTEROL+GLYCOPYRRONIUM can be used by breastfeeding mothers or not.
ARFORMOTEROL+GLYCOPYRRONIUM may cause dizziness. Drive or operate machinery only if you are alert.
Dose adjustment may be needed. Please consult your doctor before using ARFORMOTEROL+GLYCOPYRRONIUM if you have liver impairment/liver disease or any concerns regarding this.
Dose adjustment may be needed. Please consult your doctor before using ARFORMOTEROL+GLYCOPYRRONIUM if you have kidney impairment/kidney disease or any concerns regarding this.
ARFORMOTEROL+GLYCOPYRRONIUM is not recommended for children below 18years as the safety and effectiveness have not been established.
Chronic Obstructive Pulmonary Disease (COPD): It is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes). The major cause of COPD is smoking tobacco. Also, long-term exposure to fumes and chemicals may also lead to COPD. The symptoms include chronic cough, shortness of breath or wheezing (whistle sound while breathing).